Cart
sales@molnova.com
2,2-Dimethyl-5-(2,5-xylyloxy)valeramide
CAS No. 114413-97-7
2,2-Dimethyl-5-(2,5-xylyloxy)valeramide( 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanamide )
Catalog No. M28379 CAS No. 114413-97-7
2,2-Dimethyl-5-(2,5-xylyloxy)valeramide is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 68 | Get Quote |
|
| 25MG | 115 | Get Quote |
|
| 50MG | 173 | Get Quote |
|
| 100MG | 258 | Get Quote |
|
| 200MG | 388 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name2,2-Dimethyl-5-(2,5-xylyloxy)valeramide
-
NoteResearch use only, not for human use.
-
Brief Description2,2-Dimethyl-5-(2,5-xylyloxy)valeramide is a chemical compound.
-
Description2,2-Dimethyl-5-(2,5-xylyloxy)valeramide is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms5-(2,5-dimethylphenoxy)-2,2-dimethylpentanamide
-
PathwayOthers
-
TargetOther Targets
-
RecptorNa+/H+-exchanger (NHE)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114413-97-7
-
Formula Weight249.354
-
Molecular FormulaC15H23NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1ccc(C)c(OCCCC(C)(C)C(N)=O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Timothy A. Ayers, et al. Process for preparing 2-chloro-3n-(2-benzimidazolyl)-4-methyl-3-thienylamine useful as a sodium/proton exchanger type 3 inhibitor. WO2011019784A1
molnova catalog
related products
-
3,5,6,7,8,4-hexameth...
3,5,6,7,8,4′-hexamethoxyflavone is a natural product for research related to life sciences.
-
Benzophenonetetracar...
Benzophenonetetracarboxylic acid (3,3',4,4'-Benzophenonetetracarboxylic acid) is utilized in the preparation of high-performance polyimides and serves as a curing agent for epoxy resins.
-
CTPI-2
CTPI-2 is an inhibitor of mitochondrial citrate carrier SLC25A1 with(KD : 3.5 μM).?CTPI-2 inhibits glycolysis, PPARγ, and its downstream target the glucose transporter GLUT4.?
